Evaluation of Orally Administered Amcenestrant (SAR439859) in Japanese Postmenopausal Patients With Advanced Breast Cancer (AMEERA-2)

Trial Identifier:	TED15954
Sponsor:	Sanofi
Start Date:	March 2019
Primary Completion Date:	October 2020
Study Completion Date:	December 2024
Condition:	Breast Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
JAPAN, Aichi	Nagoya-shi, Aichi, JAPAN, 464-8681
JAPAN, Chiba	Kashiwa-shi, Chiba, JAPAN, 277-8577
JAPAN, Tokyo	Chuo-ku, Tokyo, JAPAN, 104-0045

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.